588 material Form 8-K filings that 519 companies we cover made with the SEC in October 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
The Ensign Group appointed Mark Parkinson, the former President and CEO of AHCA/NCAL, as a director, filling a seat created when shareholders expanded the board to nine members in May 2024. The Board determined he is independent, and he will serve until the 2025 Annual Meeting. The filing does not report financial results, so the change is a governance update rather than a change in company performance.
Mark Parkinson appointed to the Board effective October 21, 2024, after being appointed by the Board on October 17, 2024
Parkinson, age 67, served as AHCA/NCAL President and CEO for 14 years, from 2011 to 2024
Board expanded from eight to nine members by shareholder vote in May 2024; Parkinson determined to be independent
Expected to be nominated for a two-year Class II director term ending at the 2027 annual meeting
Guidewire Software issued $690 million of 1.25% convertible senior notes due November 1, 2029 on October 18, 2024, including $90 million from the initial purchasers' option. The company used part of the proceeds to buy the cost of capped call transactions and to retire about $120.9 million of its 1.25% convertible notes due March 2025, which the press release said could affect the stock price around the pricing. Shareholders face potential dilution from conversions, which the capped calls are intended to reduce up to a cap price of about $329.33 per share.
Notes: $690 million principal, 1.25% annual interest, maturing November 1, 2029, issued October 18, 2024
Initial conversion price about $244.65 per share, a premium of about 30% over the $188.19 close on October 15, 2024
Capped call transactions cost about $58.8 million, with a cap price of about $329.33 per share
About $200.5 million of net proceeds was earmarked to retire about $120.9 million of 2025 notes
Element Solutions and MacDermid entered Amendment No. 9 to their credit agreement on October 15, 2024, refinancing part of existing tranche B-2 term loans into new tranche B-3 loans of $1,041,375,000 and cutting the interest rate by 25 basis points. The company also paid down $100 million of existing term loans, and the new loans mature on December 18, 2030, the same date as the loans they replace.
New tranche B-3 term loans total $1,041,375,000, with the $100 million paydown reducing borrowings to that amount.
Initial interest rate is Term SOFR plus 1.75% per annum, a reduction of 25 basis points.
Existing swap agreements continue on the new loans, effectively fixing the rate through January 2025; the net fixed rate was approximately 3.2% at June 30, 2024.
WaFd, Inc. reported fiscal 2024 net income of $200 million, or $2.50 per diluted share, down from $257 million, or $3.72, in fiscal 2023. The results include $26.3 million of acquisition-related expenses and the February 29, 2024 Luther Burbank Corporation acquisition, which the company says makes year-over-year comparisons not directly comparable. For shareholders, the headline earnings measures declined for the year, and the company's non-GAAP adjusted EPS of $3.02 excludes those costs.
Fiscal 2024 net income was $200 million, or $2.50 per diluted share, versus $257 million, or $3.72, in fiscal 2023.
Fourth-quarter net income was $61.1 million, or $0.71 per diluted share, versus $50.2 million, or $0.72, a year earlier.
Acquisition-related expenses were $26.3 million; non-GAAP adjusted EPS for the year was $3.02.
Net interest income was $660.8 million, down 4.3% from the prior year, and total assets were $28.1 billion as of September 30, 2024.
ESCO Technologies increased the size of its Class II board seats from two to three and appointed Penelope M. Conner to fill the new seat, effective October 17, 2024. The Federal Energy Regulatory Commission approved the change on October 17, which was a required prior condition.
Class II board size increased from two to three members, effective October 17, 2024
Penelope M. Conner elected Class II director, serving a term ending at the 2025 annual meeting
Conner also joined the Nominating and Corporate Governance Committee
FERC approval granted October 17 as a prior requirement
Lancaster Colony Corporation, the filer named in this 8-K (the filing does not name Marzetti Co or ticker MZTI), said on October 17, 2024 that Carl R. Stealey, President of the Retail Division of its specialty foods subsidiary T. Marzetti Company, will leave by June 30, 2025. The company expects to sign a severance agreement with him, but its terms have not been set and will be described in a future SEC filing.
Carl R. Stealey, President, Retail Division of T. Marzetti Company, will depart effective no later than June 30, 2025
Announced October 17, 2024; 8-K dated October 18, 2024
Severance agreement expected, but terms not yet determined
Company will file a description of the severance agreement after it is signed
Ally Financial reported preliminary third-quarter 2024 results. GAAP earnings per share rose to $1.06 from $0.86 in the second quarter, helped by a $124 million tax benefit tied to EV lease tax credits, while adjusted EPS fell to $0.95 from $0.97. Shareholders get a mixed picture: GAAP revenue and net income grew, but provision for credit losses rose to $645 million and core pre-tax income fell $138 million from a year earlier.
GAAP EPS of $1.06, up from $0.86 in 2Q 24 and $0.88 in 3Q 23; adjusted EPS of $0.95, down from $0.97 in 2Q 24 and up from $0.83 in 3Q 23
GAAP total net revenue of $2,103 million, up 5% from the prior quarter and 7% from a year earlier
Provision for credit losses of $645 million, up $137 million year over year, reflecting higher net charge-offs and a 15 bps increase in the retail auto reserve rate
Ally paid a $0.30 per share quarterly dividend and declared the same amount for the fourth quarter of 2024; no shares were repurchased on the open market
F.N.B. Corporation reported third-quarter 2024 net income available to common stockholders of $110.1 million, or $0.30 per diluted share, down from $143.3 million, or $0.40, a year earlier and $123.0 million, or $0.34, in the second quarter. Non-interest income reached a record $89.7 million, but net interest income fell 1.0% from a year earlier and the company booked $15.3 million of pre-tax significant items, so shareholders see lower reported earnings despite growth in some revenue lines.
Net income to common stockholders was $110.1 million, or $0.30 per diluted share, versus $143.3 million, or $0.40, in Q3 2023 and $123.0 million, or $0.34, in Q2 2024.
Operating EPS was $0.34, excluding $0.04 per share of significant items, including an $11.6 million pre-tax loss on an indirect auto loan sale and a $3.7 million software impairment.
Non-interest income was a record $89.7 million, up 10.0% from the year-ago quarter.
Period-end total deposits rose $2.2 billion, or 6.2%, year over year, and the loan-to-deposit ratio was 92% at September 30, 2024.
SLB reported third-quarter 2024 revenue of $9.16 billion, up 10% from a year earlier, with GAAP diluted EPS of $0.83 and EPS excluding charges and credits of $0.89. The company said it accelerated its share repurchases and now expects to exceed its $3.0 billion shareholder return commitment for the year, while it expects a full-year adjusted EBITDA margin at or above 25%.
Revenue of $9.16 billion was flat sequentially and up 10% year on year; GAAP diluted EPS was $0.83, up 6% year on year
EPS excluding charges and credits was $0.89, up 14% year on year; adjusted EBITDA was $2.34 billion, up 13% year on year
SLB repurchased 11.3 million shares for $501 million in the quarter and expects to exceed its $3.0 billion full-year shareholder return commitment
Board approved a quarterly dividend of $0.275 per share, payable January 9, 2025, to holders of record on December 4, 2024
CVS Health appointed David Joyner as President and Chief Executive Officer effective October 17, 2024, replacing Karen Lynch, who also left the Board, and named Roger Farah Executive Chairman. The company also gave preliminary third quarter 2024 guidance of $0.03 to $0.08 GAAP diluted EPS and $1.05 to $1.10 Adjusted EPS, citing about $1.1 billion in premium deficiency reserve charges and about $1.2 billion in restructuring charges, and told investors not to rely on its prior guidance from August 7, 2024.
David Joyner, previously executive vice president and president of Pharmacy Services, became CEO effective October 17, 2024; Roger Farah is Executive Chairman.
Preliminary Q3 2024 GAAP diluted EPS of $0.03 to $0.08 and Adjusted EPS of $1.05 to $1.10.
Premium deficiency reserve charges of about $1.1 billion lowered Q3 Adjusted EPS by $0.63; medical benefit ratio expected at about 95.2%.
Karen Lynch will provide advisory services for six months at a $375,000 monthly fee; her non-compete extends to 30 months. Q3 earnings call is scheduled for November 6, 2024.
Regions Financial reported preliminary third-quarter 2024 results on October 18, 2024. Net income available to common shareholders was $446 million, or $0.49 per diluted share, down from $477 million and $0.52 in the second quarter, though revenue rose 3.4% from the prior quarter to $1.8 billion. Notable items, including securities repositioning and preferred stock redemption costs, reduced diluted EPS by $0.08.
Net income available to common shareholders was $446 million, versus $477 million in Q2 2024 and $465 million a year earlier.
Diluted EPS was $0.49, compared with $0.52 in Q2 2024 and $0.49 in Q3 2023; notable items reduced EPS by $0.08.
Total revenue was $1.8 billion, up 3.4% from Q2 2024 but down 3.6% from Q3 2023.
Tangible common book value per share rose to $12.26 from $10.61 in Q2; the company repurchased about 4 million shares for $101 million and declared $229 million in common dividends.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.